Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 1999;80:348-352; doi:10.1136/adc.80.4.348
Copyright © 1999 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Arch Dis Child 1999;80:348-352 ( April )

Improvement of nebulised antibiotic delivery in cystic fibrosis

Daniel Wilson,a Maria Burniston,a Eduardo Moya,b Adrian Parkin,a Stephen Smye,a Phillip Robinson,c James Littlewoodb

a Department of Medical Physics, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK, b Regional Paediatric Cystic Fibrosis Unit, St James's University Hospital, c Department of Radiology, St James's University Hospital

Correspondence to: Dr Wilson. email: djw{at}medphys.clara.net

Accepted 5 October 1998

AIM---To investigate deposition patterns and to assess the delivery rate of two nebuliser systems in children with cystic fibrosis (CF).
METHODS---Thirty three children with CF on regular treatment with nebulised antibiotics had radioisotope scans performed using technetium-99m labelled aerosol antibiotic generated by a Ventstream nebuliser (median mass diameter (MMD), 3.3 µm; delivery rate, 0.075 ml/min) under conditions similar to their routine home practice. The inhomogeneity of the images was scored on a 1-10 rating scale (a low score indicating even distribution of the antibiotic), and stomach deposition was measured as a percentage of overall deposition. Twenty patients had a repeat scan using an Optimist nebuliser (MMD, 1.8 µm; delivery rate, 0.02 ml/min).
RESULTS---The mean inhomogeneity scores were 5.4 in the Ventstream group and 3.5 in the Optimist group. Mean stomach deposition was 17.3% in the 33 patients using the Ventstream nebuliser. There was an inverse relation between height and stomach deposition (r = 0.69). In the 20 patients who had both nebulisers, the mean percentages of stomach deposition for the Ventstream and Optimist nebulisers were 11.8% and 1.6%, respectively. The Ventstream nebuliser delivered antibiotic at an average 2.8 times faster rate than the Optimist nebuliser.
IMPLICATIONS---A smaller particle size results in a more homogenous distribution of the antibiotic in the lungs with decreased stomach deposition. This should not be seen as a recommendation to use the Optimist nebuliser because more antibiotic was delivered to most parts of the lung with the Ventstream because of its increased delivery rate.

Keywords: cystic fibrosis; nebulised antibiotics; nuclear medicine; particle size


© 1999 by Archives of Disease in Childhood

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Geller, D. E., Rosenfeld, M., Waltz, D. A., Wilmott, R. W. (2003). Efficiency of Pulmonary Administration of Tobramycin Solution for Inhalation in Cystic Fibrosis Using an Improved Drug Delivery System. Chest 123: 28-36 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs